Last edition
News about "Central Nervous System (CNS) portfolio"
Dr. Reddy's Acquires STUGERON Brand from Johnson & Johnson to Strengthen CNS Portfolio
Dr. Reddy’s, a global pharmaceutical company, has announced the completion of a definitive agreement with Johnson & Johnson to acquire STUGERON and its associated brands, STUGERON FORTE and STUGERON PLUS, across 18 markets in the Asia-Pacific (APAC) and Europe, Middle East and Africa (EMEA) regions.
Central Nervous System (CNS) Portfolio | 11/09/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members